Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Dual Inhibition of IL-23 and IL-17 Offers Superior Efficacy in Mouse Models of Autoimmunity.
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.
Cdk5 regulates developmental remodeling of mushroom body neurons in Drosophila.
Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.
Cortical excitability changes over time in progressive multiple sclerosis.
Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality.
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
Heavy metals, organic solvents and multiple sclerosis: an exploratory look at gene-environment interactions.
Multiple sclerosis: Lessons from molecular neuropathology.
Brain MRI findings in Japanese patients with clinically isolated syndrome.
S1P and the birth of platelets.
Dietary interventions for multiple sclerosis.
Multicenter measurements of myelin water fraction and geometric mean T2 : Intra- and intersite reproducibility.
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
Painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder.
Goal attainment in cognitive rehabilitation in MS patients.
EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
Chronic illness and return to work: a social cognitive perspective.
A case of acute combined central and peripheral demyelination.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Contemporary treatment options for relapsing-remitting multiple sclerosis.
Age-Dependent Decline of Nogo-A Protein in the Mouse Cerebrum.
How big is the myelinating orchestra? Cellular diversity within the oligodendrocyte lineage: facts and hypotheses.
Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study.
Pages
« first
‹ previous
…
335
336
337
338
339
340
341
342
343
…
next ›
last »